Tolerating Subretinal Fluid in Neovascular Age-Related Macular Degeneration Treated with Ranibizumab Using a Treat-and-Extend Regimen FLUID Study 24-Month Results
Robyn H Guymer, Caroline M Markey, Ian L McAllister, Mark C Gillies, Alex P Hunyor, Jennifer J Arnold
Ophthalmology | ELSEVIER SCIENCE INC | Published : 2019
The FLUID study was funded by Novartis Pharmaceuticals Australia Pty. Ltd. The sponsor participated in the design of the study; conducting the study; data management; data analysis; and preparation, review, and approval of the manuscript.